Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
DarioHealth ( (DRIO) ) has issued an announcement.
On March 12, 2025, DarioHealth Corp. made a significant change in its auditing firm by appointing Kesselman & Kesselman, a member of PricewaterhouseCoopers International Limited, as its new independent registered public accounting firm, replacing Kost, Forer, Gabbay & Kasierer, a member of Ernst & Young Global. The transition comes after EY’s audit reports for the fiscal years 2023 and 2024, which were unqualified and without disagreements or reportable events, indicating a smooth handover. This strategic move might influence DarioHealth’s financial reporting and auditing processes, potentially impacting its stakeholders and market perception.
More about DarioHealth
YTD Price Performance: -20.98%
Average Trading Volume: 740,680
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $26.19M
For detailed information about DRIO stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue